Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Ingenza’s proprietary technology produces novel antimicrobial peptideBy: Ingenza Ltd “We spoke to Ingenza about using its cutting-edge inABLE® technology to produce commercially viable amounts of epidermicin in an alternative biological production host system. The company is very dynamic and wanted to engage with us, showing a real interest in the project and developing a longer term relationship with the university. With the support of an award from the InnovateUK Industrial Biotechnology Catalyst scheme, we are now working together to develop an integrated approach to the efficient production of epidermicin driven by synthetic biology. We aim to establish a method that produces from tens to hundreds of milligrams of peptide per litre of culture grown. By the end of the project, we hope to be producing sufficient quantities of peptide to carry out pre-clinical toxicity, formulation and stability type studies, eventually leading to a phase one clinical trial. That would be the ideal situation, and a perfect conclusion to the project.” For more information, visit www.ingenza.com or email sarah.scott@ End
Account Email Address Disclaimer Report Abuse
|
|